News
ARYD
11.33
0.00%
0.00
Weekly Report: what happened at ARYD last week (0422-0426)?
Weekly Report · 1d ago
ARYA Sciences Acquisition IV Announces Transformative Merger
TipRanks · 6d ago
Weekly Report: what happened at ARYD last week (0415-0419)?
Weekly Report · 04/22 10:53
Weekly Report: what happened at ARYD last week (0408-0412)?
Weekly Report · 04/15 10:46
Weekly Report: what happened at ARYD last week (0401-0405)?
Weekly Report · 04/08 10:50
ARYA SCIENCES ACQUISITION CORP IV: CO APPROVED FIRST ONE-MONTH EXTENSION OF TIME PERIOD DURING WHICH IT MAY CONSUMMATE INITIAL BUSINESS COMBINATION
Reuters · 04/02 10:11
Weekly Report: what happened at ARYD last week (0325-0329)?
Weekly Report · 04/01 10:48
Weekly Report: what happened at ARYD last week (0318-0322)?
Weekly Report · 03/25 10:50
Weekly Report: what happened at ARYD last week (0311-0315)?
Weekly Report · 03/18 10:49
Weekly Report: what happened at ARYD last week (0304-0308)?
Weekly Report · 03/11 10:46
Weekly Report: what happened at ARYD last week (0226-0301)?
Weekly Report · 03/04 10:49
Weekly Report: what happened at ARYD last week (0219-0223)?
Weekly Report · 02/26 10:59
Weekly Report: what happened at ARYD last week (0212-0216)?
Weekly Report · 02/19 11:01
Adagio Medical to go public in $113M deal with SPAC ARYA Sciences
Healthcare M&A Adagio Medical to go public in $113M deal with SPAC ARYA Sciences. AdagIO Medical specializes in catheter ablation technologies for the treatment of cardiac arrhythmias. The combined company's stock will be listed on Nasdaq.
Seeking Alpha · 02/14 14:13
ARYA Sciences’ Strategic Moves Amid Business Combination Plans
TipRanks · 02/14 14:02
*Arya, Adagio Medical: Deal Implies Post-Transaction Fully Diluted Equity Value of $128 Million >ARYD
Dow Jones · 02/14 11:09
*Arya, Adagio Medical: Combined Company to Receive $42M From Equity, Convertible Note Investors at Closing >ARYD
Dow Jones · 02/14 11:08
*Adagio Medical to Combine With ARYA Sciences Acquisition IV >ARYD
Dow Jones · 02/14 11:07
Press Release: Adagio Medical To List on Nasdaq Through Business Combination with ARYA Sciences Acquisition Corp IV, Enabling Further Commercial and Clinical Development of Innovative Cardiac Ablation Technologies
Adagio Medical To List on Nasdaq Through Business Combination with ARYA Sciences Acquisition Corp IV, Enabling Further Commercial and Clinical Development of Innovative Cardiac Ablation Technologies. Combined Company expects to receive approximately $42 million from equity and convertible note investors at closing. The company's common stock is expected to be listed on the Nasdaq Capital Market in 2024.
Dow Jones · 02/14 11:07
*Adagio Medical to List on Nasdaq Through Business Combination With ARYA Sciences Acquisition Corp IV >ARYD
Dow Jones · 02/14 11:07
More
Webull provides a variety of real-time ARYD stock news. You can receive the latest news about Arya Sciences Acquisition Corp Iv through multiple platforms. This information may help you make smarter investment decisions.
About ARYD
ARYA Sciences Acquisition Corp IV is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company is focused on healthcare or healthcare related industries. The Company has no operations and has not generated revenues.